RWB
DGX icon

RMR Wealth Builders’s Quest Diagnostics DGX Stock Holding History

RMR Wealth Builders’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-140
Closed -$18K – 299
2021
Q1 		$18K Hold
140
– – ﹤0.01% 526
2020
Q4 		$17K Buy
+140
New +$17.1K 0.01% 365
2020
Q3 		– Sell
-310
Closed -$35K – 286
2020
Q2 		$35K Buy
+310
New +$32.9K 0.03% 260
2019
Q4 		$42K Buy
+395
New +$41.2K 0.04% 246

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

RMR Wealth Builders's DGX Position: Q2 2021 in Review

RMR Wealth Builders sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 140 shares — an estimated $18K sold.

RMR Wealth Builders first reported a position in DGX in Q4 2019 and held it in 4 quarters. The position peaked at $42K in Q4 2019. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

  • RMR Wealth Builders reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 140 Quest Diagnostics shares in Q2 2021, an estimated $18K.
  • RMR Wealth Builders first reported a position in Quest Diagnostics in Q4 2019 and held it in 4 quarters.
  • RMR Wealth Builders's Quest Diagnostics position peaked at $42K in Q4 2019.
  • 814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.